Skip to ContentSkip to Navigation
breed in kennis  -  sterk in techniek
Over ons Praktische zaken Waar vindt u ons prof. dr. G.A. Huls

Publicaties

Author Correction: Whole-body CD8+ T-cell PET imaging in patients with large B-cell lymphoma before and during CD19-directed CAR T-cell therapy: a phase 2 study.

A versatile and GMP-compliant bead-based IFN-γ potency assay for standardized quality control and release testing of CAR-T cell drug products

Comparability of external and internal control patients for the prospective randomized HOVON-103 trial in older AML patients

Decitabine Conditioning Improves Natural Killer Cell Maturation and Limits CD8+T Cell Terminal Differentiation Post-Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia Patients

DNMT3A clonal hematopoiesis is associated with cardiovascular disease in women

Drivers of clinical resistance to venetoclax and hypomethylating agents in acute myeloid leukemia and strategies for improving efficacy

Flow Cytometry-Based Measurable Residual Disease Assessment in Patients With Acute Myeloid Leukemia Receiving Non-Intensive Chemotherapy

Hyperglycaemia as a predictor of morbidity and mortality in patients receiving an allogeneic haematopoietic stem cell transplantation

Impact of Rituximab Maintenance on Survival in Patients with Mantle Cell Lymphoma; a Population-based Cohort Study

Metformin induces ferroptosis associated with lipidomic remodeling in AML

Pers/media

Professor Dr. Gerwin Huls te gast bij Nutsdepartement Vlagtwedde

Professor Dr. Gerwin Huls te gast bij Nutsdepartement Vlagtwedde

Nationaal Groeifonds investeert in UMCG-studies om ontwikkeling kankermedicijnen te versnellen

Sustainable Development Goals

SDG 3 – Goede gezondheid en welzijnSDG 9 – Industrie, innovatie en infrastructuur

Meer informatie over de Sustainable Development Goals.